Skip to main content
. 2017 Apr 14;3(3):196–199. doi: 10.1016/j.jdcr.2017.02.004

Fig 3.

Fig 3

Primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Status directly after the CHOEP regimen.